The Journal of Rheumatology


 

Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis

42 views
May 2, 2022
0 Comments
Login to view comments. Click here to Login
Videos